Cleared Traditional

K091188 - ASAHI ZENYTEEX GUIDING CATHETER

K091188 is an FDA 510(k) clearance for ASAHI ZENYTEEX GUIDING CATHETER, manufactured by Asahi Intecc Co., Ltd.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 309-day FDA review.

K091188 · Asahi Intecc Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2010
Decision
309d
Days
Class 2
Risk

K091188 is an FDA 510(k) clearance for the ASAHI ZENYTEEX GUIDING CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Asahi Intecc Co., Ltd. (Santa Ana, US). The FDA issued a Cleared decision on February 26, 2010 after a review of 309 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Asahi Intecc Co., Ltd. devices

FDA 510(k) Submission Details - K091188

510(k) Number K091188 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 23, 2009
Decision Date February 26, 2010
Days to Decision 309 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
184d slower than avg
Panel avg: 125d · This submission: 309d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 725
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K091188.
PENUMBRA CATHERER 025
K100826 · Penumbra, Inc. · Jul 2010
CLEARWAY OTW MODEL 85912
K093431 · Atrium Medical Corp. · Apr 2010
ACUITY BREAK-AWAY GUIDE CATHETER
K093969 · Cardiac Pacemakers, Inc. · Mar 2010
ARROW SELDINGER ARTERIAL CATHERIZATION DEVICES, MODELS EX SAC 00520
K093050 · Arrow Intl., Inc. · Dec 2009
SCOUTPRO 7F LONG CATHETERS
K093303 · Biotronik, Inc. · Nov 2009
ENVOY GUIDING CATHETERS
K093184 · Codman & Shurtleff, Inc. · Nov 2009